Live Breaking News & Updates on Motor Examination

Stay updated with breaking news from Motor examination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Topline results announced from phase 2 trial of treatment for early Parkinson's disease

Neuraly has announced that its investigational NLY01 did not meet the primary study endpoint of improvement in motor symptoms in patients with early, untreated Parkinson’s disease.According to a company release, NLY01 is a long-acting analogue of exendin-4, a glucagon-like peptide-1 receptor agonist. In an ongoing phase 2 trial, NLY01 did not achieve statistically significant change from ....

United States , Viktor Roschke , Heather Biele , Motor Experiences , Daily Living , Motor Examination ,